Company page

Samyang Biopharm Corporation

Samyang Biopharm Corporation, traded under the ticker 0120G0, is a public company based in Korea with a market capitalization of approximately 295.96 million USD. The company specializes in biopharmaceuticals, focusing on developing innovative therapies. Samyang Biopharm is committed to advancing healthcare solutions and improving patient outcomes through its research and development efforts.